semaglutide 0.3 mg (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss Novo Nordisk to Seek Approval

Trials for Tirzepatide, a dual GLP-1/GIP (glucagon-like peptide-1 / glucose-dependent insulinotropic polypeptide) agonist, show up to 22.5% body weight reduction

The reduction in LFC was about 4.7% greater with tirzepatide than with insulin degludec

Corrado, A

It is a gold mine of legislative issue and hearing information, and resource links, plus: you can sign up for e-News

Heres what to do Work with your provider or a nutrition professional for a more precise estimate

The largest difference in payments was for hospital care, with Black Medicare beneficiaries incurring 1.6 times as much in hospital care costs as White beneficiaries ($9,908 versus $6,372)